Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Hematology"
DOI: 10.1007/s12185-021-03231-6
Abstract: Isolated extramedullary relapse (EMR) without bone marrow relapse (BMR) after allogeneic hematopoietic cell transplantation (allo-HCT) is a rare condition in patients with acute lymphoblastic leukemia (ALL), and the role of immunotherapeutic agents for these patients… read more here.
Keywords: response; extramedullary relapse; isolated extramedullary; blinatumomab ... See more keywords
Very late extramedullary relapse of acute myeloid leukaemia as prostatic myeloid sarcoma occurring 24 years postâallograft
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18038
Abstract: year- old boy myeloid leukaemia daunorubicin cycle cytarabine and a cycle of high dose cytarabine and He underwent a total based myeloablative transplant from a human leucocyte antigen matched sibling trans-plantation complicated by acute skin… read more here.
Keywords: late extramedullary; relapse acute; myeloid; myeloid leukaemia ... See more keywords
Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14246106
Abstract: Simple Summary Extramedullary relapse of multiple myeloma (MM) is often resistant to existing treatments, and has an extremely poor prognosis. Therefore, early identification of high-risk extramedullary relapse patients has important clinical significance. However, due to… read more here.
Keywords: risk extramedullary; high risk; relapse; extramedullary relapse ... See more keywords